Revolution Medicines, Inc. <RVMD.O>: Oppenheimer raises target price to $260 from $230
RVMD•Related News
Sempra begins permitting process for major LNG expansion in Texas
SRE•
Sempra wants to build new LNG plant in South East Texas, regulator filing shows
SRE•
Tenet Healthcare director Cecil D. Haney sells 1,300 common shares worth $361,439.00
THC•
Oil prices extend losses on expectations talks to ease Middle East supply woes
XLE•
Okta, Inc. <OKTA.O>: Raymond James Raises Target Price to $185 From $115
OKTA•